Gateshead residents invited to take part in Covid-19 vaccination research
The NHS are offering Gateshead's residents the opportunity to contribute to Covid-19 vaccine research that will have 'real world impacts'.
There are now a number of approved vaccines that prevent Covid-19. Each of these requires a first 'prime' dose, followed by a second 'boost' dose. The purpose of this research is to observe how well people's immune systems respond when the boost dose is a different type of vaccine from their prime dose. This is important as being able to use different vaccines in this way will create a must more flexible vaccination programme, potentially allowing more people to be immunised for quickly.
They are seeking men and women aged 50 years and over, of all ethnicities, who've already had one dose of a Covid-19 vaccine between 25 January and 20 March 2021. Participation would last approximately 10 months, with meaningful results expected as early as July 2021.
The benefits to those taking part, apart from the opportunity to be part of pandemic response research, is that you will receive your second vaccine earlier that expected and likely gain additional protection against Covid-19.
For more information and to register your interest in the study please visit the Comparing Covid-19 Vaccine Schedule Combinations website (opens new window).
The NHS are offering Gateshead's residents the opportunity to contribute to Covid-19 vaccine research that will have 'real world impacts'.
There are now a number of approved vaccines that prevent Covid-19. Each of these requires a first 'prime' dose, followed by a second 'boost' dose. The purpose of this research is to observe how well people's immune systems respond when the boost dose is a different type of vaccine from their prime dose. This is important as being able to use different vaccines in this way will create a must more flexible vaccination programme, potentially allowing more people to be immunised for quickly.
They are seeking men and women aged 50 years and over, of all ethnicities, who've already had one dose of a Covid-19 vaccine between 25 January and 20 March 2021. Participation would last approximately 10 months, with meaningful results expected as early as July 2021.
The benefits to those taking part, apart from the opportunity to be part of pandemic response research, is that you will receive your second vaccine earlier that expected and likely gain additional protection against Covid-19.
For more information and to register your interest in the study please visit the Comparing Covid-19 Vaccine Schedule Combinations website (opens new window).
